Abbott’s trial arrives in the wake of a growing IVL market. Johnson & Johnson has a FDA-approved technology, gaining access ...

A German medical device manufacturer of defibrillation and patient monitoring systems is on the cusp of concluding a ...

Aditxt subsidiary Pearsanta has acquired patents associated with adductomics-based DNA damage detection to advance cancer ...

The FDA has granted 510(k) approval for UK-based Huntleigh Healthcare’s Dawes-Redman CTG Analysis for foetal monitoring ...

Abbott’s CGM device, the FreeStyle Libre, has been integrated with Glooko’s digital platform for diabetes management.

Alcon has signed a definitive merger agreement to acquire Lensar to enhance its portfolio of cataract equipment and technology.

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025.

The agency has published a list of 24 high-risk infectious diseases as a reference tool for funders and researchers.

Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.

23andMe has filed for bankruptcy protection in the US as the failing business attempts to materialise what little value it ...

The FDA has cleared Vent Creativity’s Hermes Knee, an AI-driven software solution for knee arthroplasty procedures.

A report by Irish Medtech has found that economic uncertainties and sector growth are among the chief concerns for sector ...